-- 根据澳新银行（ANZ）周三发布的报告，新西兰第一季度失业率预计将维持在5.4%的稳定水平，略低于此前预测的5.5%。 报告指出，澳新银行将季度就业增长预期上调0.1个百分点至0.3%，3月份就业增长势头似乎比预期更为强劲。 即将公布的带薪工时和实际工时数据或许能反映出第一季度GDP环比增长0.8%预期面临的风险，但由于劳动力市场通常是最后一个对经济环境变化做出反应的行业，因此近期石油危机的影响可能尚未显现。 预计第一季度劳动力市场数据显示，市场拥有足够的过剩产能，足以缓冲近期石油危机的影响，从而降低劳动力成本在短期内推高通胀的风险。
Related Articles
Asia
JCET's Q1 Profit Jumps 43%, Revenue Slips 2%
JCET's (SHA:600584) net profit attributable to shareholders in the first quarter jumped 43% to 290.3 million yuan from 203.4 million yuan a year earlier, according to a Shanghai bourse filing on Wednesday.Earnings per share rose 45% year on year to 0.16 yuan from 0.11 yuan.Operating revenue slipped 1.8% to 9.17 billion yuan from 9.34 billion yuan in the preceding year.The shares of the Chinese integrated circuit manufacturer dropped less than 3% during midday trade.
$SHA:600584
Asia
Update: G8 Education to Suspend Operation of Around 40 Centers, Shares Reach 16-Year Low
(Updates to add the stock movement in the sixth paragraph)G8 Education (ASX:GEM) plans to suspend the operation of around 40 of its centers as a result of an assessment of its network, according to a Wednesday Australian bourse filing.It will transition customers to one of the nearby centers and, where possible, redeploy team members. The firm will then consider longer-term options for those centers, including lease surrender, divestment, or other alternatives.The firm will also reorganize its support office structure and reduce its cost base.Its current spot occupancy as of April 24 came in at 56.4%, down 7% year-over-year, while year-to-date occupancy was 56.1%, down 7.9% versus the prior corresponding period.Occupancy across the early childhood education and care sector is lower compared to previous years due to sustained affordability pressures, falling birth rates, increased long-day care supply, and confidence impacted by serious child safety incidents, the filing noted.Its shares fell 25% in recent trading on Wednesday, earlier reaching a 16-year low.
$ASX:GEM
Asia
Fosun Pharmaceutical Reports 14% Higher Profit in Q1
Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) logged a 14% rise in its attributable profit for the first quarter of 2026 to 870.8 million yuan from 764.8 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.The pharmaceutical company's Hong Kong shares fell nearly 2% in late morning trade Wednesday.Earnings per share were 0.33 yuan, compared with 0.29 yuan in the prior year.Operating revenue gained nearly 7% to 10.1 billion yuan, figures showed.
$HKG:2196$SHA:600196